BOSTON SCIENTIFIC CORP — Director's Dealing 2020

Sep 30, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Pulmonx Corp (LUNG)
CIK: 0001127537
Period of Report: 2020-09-30

Reporting Person: BOSTON SCIENTIFIC CORP (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	141.0000	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series A-1 Preferred Stock	$		Common Stock (40705.0000)		Direct
Series B-1 Preferred Stock	$		Common Stock (47536.0000)		Direct
Series C-1 Preferred Stock	$		Common Stock (23180.0000)		Direct
Series D-1 Preferred Stock	$		Common Stock (542.0000)		Direct
Series E-1 Preferred Stock	$		Common Stock (6215.0000)		Direct
Series F-1 Preferred Stock	$		Common Stock (3787878.0000)		Direct
Series G-1 Preferred Stock	$		Common Stock (2081909.0000)		Direct

Footnotes

F1: Each share of Preferred Stock automatically converts on a one-for-one basis into Common Stock at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Stock has no expiration date.